Power Law company profile

Acerta Pharma

Biotech & Life Sciences · Oss, Netherlands · Founded 2013 Unicorn

Clinical research on cancer and autoimmune diseases

Valuation

$5–10B

Latest valuation · 2026

Unlock exact value

Revenue

$100–500M

Latest reported FY

Unlock exact value

Headcount

100–500

Current team size

Unlock exact value

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026 $10B+ revenueThoroughbred · Power Law outcome

Investors

3 investors on Acerta Pharma's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 1 investor entered at this stage

BioGeneration Ventures

Series A 2 investors entered at this stage

Frazier Healthcare Partners

OrbiMed

Global footprint

Where Acerta Pharma has talent and traffic

AI talent share

2.1% of workforce is AI talent
(3 of 145 staff)

Core AI10.69%

Other AI21.38%

Non-AI workforce14297.93%

Workforce by country

11 countries with
team presence

🇳🇱 Netherlands78%

🇺🇸 United States9.5%

🇬🇧 United Kingdom2.9%

🇩🇪 Germany2.7%

🇫🇷 France1.7%

Top 5 of 11 shown

Web traffic by country

360 monthly visits
across markets

🇳🇱 Netherlands111.1%

Top 1 markets shown

Patent intelligence

$46M patent portfolio · 27 active families

Estimated portfolio value

$46M

0.66% of valuation · 16.8× smaller than top peer BioNTech ($780M)

27 active patent families

Where Acerta Pharma innovates Molecular biologyPharmaceutical drugCarcinosisKinase inhibitionProdrug

Where Acerta Pharma concentrates vs peers

Each axis is a top-10 topic across Acerta Pharma and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Acerta Pharma

An AI-synthesized read of the highest-engagement posts about Acerta Pharma on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Acerta Pharma on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles